EZH2 and prostate carcinoma: In mouse and human prostate cancer organoids models, inhibition of EZH2 increased the expression of the Th1 attracting-chemokines CXCL9 and CXCL10 and derepressed endogenous double-strand RNA (ds RNA) expression.